CDNA 250516 17.50C(CDNA250516C17500) Stock Price Today | Quotes & News - Moomoo

US OptionsDetailed Quotes

CDNA250516C17500

Watchlist

0.21
-0.29-58.00%

15min DelayClose May 5 16:00 ET

0.21High0.05Low

Intraday

5D
Daily

News

H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Maintains Target Price $25
Moomoo News02:46 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Neutral on CareDx, Maintains $25 Price Target
BenzingaMay 5 07:25 ET
CareDx Analyst Ratings
BenzingaMay 5 07:24 ET · Ratings
CareDx: Balancing Growth and Challenges With a Hold Rating
TipRanksMay 5 06:45 ET · Ratings
Wells Fargo Maintains CareDx(CDNA.US) With Hold Rating, Cuts Target Price to $19
Moomoo NewsMay 3 02:31 ET · Ratings
An Intrinsic Calculation For CareDx, Inc (NASDAQ:CDNA) Suggests It's 28% Undervalued
Yahoo FinanceMay 2 08:02 ET

Comments

CareDx Launches Two Expanded Indications for AlloSure Testing Services

$CareDx (CDNA.US)$
Major Breakthrough: CareDx AlloSure Now Covers Infant Heart and Dual-Organ Transplant Testing

CareDx Launches Two Expanded Indications for AlloSure Testing Services

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

$CareDx (CDNA.US)$
Revolutionary Transplant Detection Test Matches Gold Standard in 580-Patient Study

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

$CareDx (CDNA.US)$
Revolutionary Cancer Detection: CareDx Study Reveals 36-Day Early Warning System for Leukemia Relapse

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

$CareDx (CDNA.US)$
Revolutionary Cancer Detection: CareDx Study Reveals 36-Day Early Warning System for Leukemia Relapse

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

thanks Amy

Share Your Profit/Loss

Read more